T2 Biosystems Inc 's ability to collect accounts receivable sequentially worsen to 4.85, indicating more challenging environment then in the second quarter 2024, but still, it is a far cry from any concerns. T2 Biosystems Inc 's Accounts Receivable average collection period in the Sep 30 2024 quarter, has increased to 75 days, from 69 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 400 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 2711 to 3235.

What is Receivable Turnover Ratio?
What is T2 Biosystems Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TTOO Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	78.49 %	-3.85 %	20.03 %	-34.35 %	-27.82 %
Y / Y Revenue Change	34.85 %	-0.61 %	-0.82 %	-69.38 %	-59.97 %
Receivable Turnover Ratio (TTM)	4.85	5.26	5.22	5.5	7.36
TTOO's Total Ranking	# 3235	# 2711	# 2330	# 2650	# 2699
Accounts Receivable average collection period days	75	69	70	66	50
Seq. Receivable Change	56.75 %	-18.32 %	11.83 %	24.67 %	-15.57 %
Seq. Revenue Change	1.69 %	-5.29 %	22.75 %	14.06 %	-25.05 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 152
Healthcare Sector	# 401
Overall Market	# 3235

Receivable Turnover Ratio Statistics
High	Average	Low
0.53	0.27	0.05
(Dec 31 2022)		(Sep 30 2017)

TTOO Company Profile • Back to TTOO Efficiency Comparisons • Compare TTOO Receivables Turnover Ratio to its Competitors

Financial Statements
T2 Biosystems Inc 's Accounts Receivable	$ 2 Millions	Visit TTOO's Balance sheet
T2 Biosystems Inc 's Sales TTM	$ 8 Millions	Visit TTOO's Income Statement
Sources of TTOO's Revenues		Visit TTOO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TTOO's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TTOO's Growth Rates	TTOO's Roa	TTOO's Inventory Turnover Ratio	TTOO's Dividend Comparisons
TTOO's Profitability Ratios	TTOO's Roi	TTOO's Asset Turnover Ratio	TTOO's Dividend Growth
TTOO's Valuation Ratios	TTOO's Roe	TTOO's Financial Strength Ratios	TTOO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Sunlink Health Systems Inc	10.38	$ 32.502 Millions	$ 3.130 Millions
Option Care Health Inc	10.33	$ 4,774.651 Millions	$ 462.140 Millions
Strata Critical Medical Inc	10.00	$ 241.814 Millions	$ 24.190 Millions
Lensar Inc	9.96	$ 48.868 Millions	$ 4.908 Millions
Immucell Corporation	9.94	$ 22.633 Millions	$ 2.276 Millions
Generation Bio Co	9.90	$ 18.582 Millions	$ 1.877 Millions
Myomo Inc	9.90	$ 25.536 Millions	$ 2.580 Millions
Quidelortho Corp	9.89	$ 2,817.700 Millions	$ 284.850 Millions
Adma Biologics Inc	9.69	$ 381.124 Millions	$ 39.324 Millions
Wave Life Sciences Ltd	9.58	$ 53.610 Millions	$ 5.594 Millions
Dyadic International Inc	9.55	$ 3.365 Millions	$ 0.352 Millions
AnTix Holdings, Inc.	9.53	$ 1.773 Millions	$ 0.186 Millions
Sanuwave Health Inc	9.52	$ 29.302 Millions	$ 3.078 Millions
Surmodics Inc	9.51	$ 126.078 Millions	$ 13.257 Millions
Atara Biotherapeutics Inc	9.47	$ 174.462 Millions	$ 18.425 Millions
Rockwell Medical inc	9.39	$ 97.946 Millions	$ 10.430 Millions
Equillium Inc	9.33	$ 45.914 Millions	$ 4.921 Millions
Clearpoint Neuro Inc	9.31	$ 30.429 Millions	$ 3.268 Millions
Dianthus Therapeutics Inc	9.21	$ 6.811 Millions	$ 0.740 Millions
Inspire Medical Systems inc	9.09	$ 753.402 Millions	$ 82.919 Millions
Twist Bioscience Corporation	9.06	$ 312.974 Millions	$ 34.560 Millions
United Therapeutics Corporation	9.05	$ 2,756.200 Millions	$ 304.675 Millions
Novocure Limited	8.95	$ 577.738 Millions	$ 64.519 Millions
Biolase Inc	8.95	$ 43.720 Millions	$ 4.886 Millions
Vaso Corporation	8.93	$ 79.094 Millions	$ 8.856 Millions
Alpha Pro Tech Ltd	8.93	$ 57.630 Millions	$ 6.454 Millions
The Pennant Group Inc	8.92	$ 652.302 Millions	$ 73.146 Millions
Biotricity Inc	8.84	$ 12.620 Millions	$ 1.428 Millions
Escalon Medical Corp	8.81	$ 11.818 Millions	$ 1.341 Millions
Enanta Pharmaceuticals Inc	8.80	$ 67.635 Millions	$ 7.688 Millions

Date modified: 2026-08-29T17:26:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.